Patent: 6,066,317
✉ Email this page to a colleague
Summary for Patent: 6,066,317
Title: | Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells |
Abstract: | A novel mammalian cytokine, IL-11, and processes for producing it are disclosed. IL-11 may be used in pharmaceutical preparations for stimulating and/or enhancing cells involved in the immune response and cells involved in the proper functioning of the hematopoietic system. |
Inventor(s): | Yang; Yu-Chung (Indianapolis, IN), Bennett; Frances K. (Melrose, MA), Paul; Stephan R. (Wyncote, PA) |
Assignee: | Genetics Institute, Inc. (Cambridge, MA) |
Application Number: | 09/122,525 |
Patent Claims: | see list of patent claims |
Details for Patent 6,066,317
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Wyeth Pharmaceuticals Inc. | NEUMEGA | oprelvekin | For Injection | 103694 | November 25, 1997 | ⤷ Sign Up | 2009-11-22 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,066,317
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 199096 | ⤷ Sign Up |
Australia | 644389 | ⤷ Sign Up |
Australia | 6757890 | ⤷ Sign Up |
Canada | 2069428 | ⤷ Sign Up |
Germany | 69033700 | ⤷ Sign Up |
Denmark | 0504177 | ⤷ Sign Up |
Denmark | 66692 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |